Ozempic Suicide Risks Result in Investigation by European Medicines Agency
Three cases of suicidal ideation have been reported in Iceland, all linked to Ozempic's active ingredient, semaglutide
Three cases of suicidal ideation have been reported in Iceland, all linked to Ozempic's active ingredient, semaglutide
Health experts warn Ozempic and Wegovy use before surgery may increase the risk of vomiting, nausea and suffocation while under anesthesia.
Ozempic and Wegovy have been increasingly used by non-diabetics for weight loss in the U.S., raising concerns about the potential risks of thyroid cancer affecting a much larger portion of the population.
Some compounded versions of Ozempic and Wegovy use salt forms of the active ingredient which have not been tested or approved by the agency.
A leading hair loss expert warns that Ozempic problems may lead to androgenic alopecia, a progressive and permanent form of pattern baldness.
Some users say the Ozempic and Wegovy hair loss does not appear to be linked to weight loss caused by the diabetes drugs